The House Committee on Energy and Commerce has given final approval to the Designer Anabolic Steroid Control Act (DASCA) after making some technical changes to win Food and Drug Administration and Drug Enforcement Administration agreement.
The Designer Anabolic Steroid Control Act of 2014, which would amend the Controlled Substances Act, would simplify things for enforcement agencies to bring criminal and civil actions against companies who spike dietary supplements with illegal drugs.
This act would ensure that anabolic androgenic steroids are not misrepresented by fraudulent sellers are legitimate dietary supplements. DASCA broadens the definition of anabolic steroids and imposes tougher penalties on firms that make and sell steroids. The Designer Anabolic Steroid Control Act seeks to amend the Controlled Substances Act to add more than 25 new substances to the current list of defined steroids. The Designer Anabolic Steroid Control Act also revises the processes whereby new substances can be added under the act in the future besides creating tougher penalties of up to $2.5 million and up to 10 years in prison for manufacturing, selling, and/or distributing of substances that fall under the definition of anabolic steroids.
Health Sub-committee Chairman Joe Pitts (R-PA) remarked that this bill would end a loophole that allows designer anabolic steroids to easily be found online, in gyms, and even in retail stores. Pitts added DASCA will help protect consumers from harmful products as it will give authority and tools to the DEA for properly classifying designer steroids as controlled substances and increase criminal penalties for importing, manufacturing, or distributing them under false labels.
In February, the Council for Responsible Nutrition (CRN) said among the improvements brought about by DASCA will be new guidelines for DEA to address products that are ‘substantially similar’ to anabolic steroids and that have been illegally marketed to promote muscle growth. CRN added DASCA in addition will place new anabolic steroids on the DEA Controlled Substance List, and will change the criteria for placing additional anabolic steroids on the list going forward. It was also remarked that the Designer Anabolic Steroid Control Act of 2014 will also allow DEA to respond faster to stop those criminals who create new anabolic substances closely resembling listed ones, but tweaked just enough that they are not identical to their flagged counterparts.
In May, CRN’s CEO and president Steve Mister, said that anabolic steroids have no business being sold as supplements and anabolic steroids are not dietary supplements. CRN and industry members had urged lawmakers to oppose the Dietary Supplement Labeling Act introduced in 2013 by Senators Dick Durbin (D-IL) and Richard Blumenthal (D-CT). It was remarked that this bill would require pre-registration of dietary supplement facilities with FDA, including registering product descriptions, ingredient lists, and copies of labels, and updating the Food and Drug Administration on of any changes. The bill was termed "misguided" by CRN as it c contained duplicative requirements that already exist under current law that gives FDA the proper legal authority to take action to protect consumers and maintain safety standards.